心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2021 NICE指南：房颤的诊断和管理（NG.196）

2021-04-27 英国国家卫生与临床优化研究所 NICE官网

房颤

2021年4月，英国国家卫生与临床优化研究所 (NICE)发布了房颤的诊断和管理指南，主要内容涵盖了成人房颤的诊断和管理，为房颤患者提供最佳护理和治疗提供指导，涉及评估，卒中风险和出血的管理。

中文标题：

2021 NICE指南：房颤的诊断和管理（NG.196）

英文标题：

NICE guideline [NG196]：Atrial fibrillation: diagnosis and management

发布机构：

英国国家卫生与临床优化研究所

发布日期：

2021-04-27

简要介绍：

2021年4月，英国国家卫生与临床优化研究所 (NICE)发布了房颤的诊断和管理指南，主要内容涵盖了成人房颤的诊断和管理，为房颤患者提供最佳护理和治疗提供指导，涉及评估，卒中风险和出血的管理。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 NICE指南：房颤的诊断和管理（NG.196）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=dd2c31c0020930e5, title=2021 NICE指南：房颤的诊断和管理（NG.196）, enTitle=NICE guideline [NG196]：Atrial fibrillation: diagnosis and management, guiderFrom=NICE官网, authorId=0, author=, summary=2021年4月，英国国家卫生与临床优化研究所 (NICE)发布了房颤的诊断和管理指南，主要内容涵盖了成人房颤的诊断和管理，为房颤患者提供最佳护理和治疗提供指导，涉及评估，卒中风险和出血的管理。, cover=https://img.medsci.cn/202158/1620486811575_2020535.jpg, journalId=0, articlesId=null, associationId=85, associationName=英国国家卫生与临床优化研究所, associationIntro=英国国家卫生与临床优化研究所（NICE，National Institute for Health and Clinical Excellence）是NHS的组织，设在伦敦和曼彻斯特。NICE成立于1999年4月1日，目标是确保每个英格兰和威尔士人平等享有NHS医疗的机会。NICE制定指南，设定质量标准，管理国家数据库，为NHS、当地权威部门和其他组织提供指南。, copyright=0, guiderPublishedTime=Tue Apr 27 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年4月，英国国家卫生与临床优化研究所 (NICE)发布了房颤的诊断和管理指南，主要内容涵盖了成人房颤的诊断和管理，为房颤患者提供最佳护理和治疗提供指导，涉及评估，卒中风险和出血的管理。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=364, tagName=房颤)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=364, guiderKeyword=房颤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7202, appHits=1061, showAppHits=0, pcHits=2268, showPcHits=6138, likes=3, shares=75, comments=40, approvalStatus=1, publishedTime=Sat May 08 23:28:46 CST 2021, publishedTimeString=2021-04-27, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat May 08 23:13:36 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 00:18:29 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 NICE指南：房颤的诊断和管理（NG.196）.pdf)])
2021 NICE指南：房颤的诊断和管理（NG.196）.pdf
下载请点击：
评论区 (35)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1219468, encodeId=f9a61219468cc, content=学习了，收益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6de78157387, createdName=ms5000001899709557, createdTime=Fri May 13 21:26:40 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203654, encodeId=f2ea1203654a2, content=好好学习，才能在临床从容不迫！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hkBfzo6cRvbR7e9fJhbElibI77mNBsDDibeHJyWjA4UdPoicSViaMb9ddJjJHUSia6M6FNHpmcrJiaQibJwfiab9tIGIVg/132, createdBy=26d31663249, createdName=1ddf3cfcm49(暂无匿称), createdTime=Fri Mar 18 00:00:34 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194294, encodeId=4b33119429492, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220112/bf73f3305cad43df9d8c6383e4c80a11/dd38f5d3971d483f90e3f37da7df323a.jpg, createdBy=13b76462298, createdName=ms尼, createdTime=Thu Feb 17 08:13:22 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083810, encodeId=103f10838103a, content=需要好好学习英文了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5bc5435970, createdName=ms5000001325769072, createdTime=Fri Dec 24 10:12:57 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083276, encodeId=b2e210832e6db, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f0d6166186, createdName=ms5000000939453647, createdTime=Wed Dec 22 23:21:19 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-05-13 ms5000001899709557

    学习了，收益匪浅

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1219468, encodeId=f9a61219468cc, content=学习了，收益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6de78157387, createdName=ms5000001899709557, createdTime=Fri May 13 21:26:40 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203654, encodeId=f2ea1203654a2, content=好好学习，才能在临床从容不迫！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hkBfzo6cRvbR7e9fJhbElibI77mNBsDDibeHJyWjA4UdPoicSViaMb9ddJjJHUSia6M6FNHpmcrJiaQibJwfiab9tIGIVg/132, createdBy=26d31663249, createdName=1ddf3cfcm49(暂无匿称), createdTime=Fri Mar 18 00:00:34 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194294, encodeId=4b33119429492, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220112/bf73f3305cad43df9d8c6383e4c80a11/dd38f5d3971d483f90e3f37da7df323a.jpg, createdBy=13b76462298, createdName=ms尼, createdTime=Thu Feb 17 08:13:22 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083810, encodeId=103f10838103a, content=需要好好学习英文了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5bc5435970, createdName=ms5000001325769072, createdTime=Fri Dec 24 10:12:57 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083276, encodeId=b2e210832e6db, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f0d6166186, createdName=ms5000000939453647, createdTime=Wed Dec 22 23:21:19 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-03-18 1ddf3cfcm49(暂无匿称)

    好好学习，才能在临床从容不迫！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1219468, encodeId=f9a61219468cc, content=学习了，收益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6de78157387, createdName=ms5000001899709557, createdTime=Fri May 13 21:26:40 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203654, encodeId=f2ea1203654a2, content=好好学习，才能在临床从容不迫！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hkBfzo6cRvbR7e9fJhbElibI77mNBsDDibeHJyWjA4UdPoicSViaMb9ddJjJHUSia6M6FNHpmcrJiaQibJwfiab9tIGIVg/132, createdBy=26d31663249, createdName=1ddf3cfcm49(暂无匿称), createdTime=Fri Mar 18 00:00:34 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194294, encodeId=4b33119429492, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220112/bf73f3305cad43df9d8c6383e4c80a11/dd38f5d3971d483f90e3f37da7df323a.jpg, createdBy=13b76462298, createdName=ms尼, createdTime=Thu Feb 17 08:13:22 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083810, encodeId=103f10838103a, content=需要好好学习英文了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5bc5435970, createdName=ms5000001325769072, createdTime=Fri Dec 24 10:12:57 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083276, encodeId=b2e210832e6db, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f0d6166186, createdName=ms5000000939453647, createdTime=Wed Dec 22 23:21:19 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-02-17 ms尼

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1219468, encodeId=f9a61219468cc, content=学习了，收益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6de78157387, createdName=ms5000001899709557, createdTime=Fri May 13 21:26:40 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203654, encodeId=f2ea1203654a2, content=好好学习，才能在临床从容不迫！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hkBfzo6cRvbR7e9fJhbElibI77mNBsDDibeHJyWjA4UdPoicSViaMb9ddJjJHUSia6M6FNHpmcrJiaQibJwfiab9tIGIVg/132, createdBy=26d31663249, createdName=1ddf3cfcm49(暂无匿称), createdTime=Fri Mar 18 00:00:34 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194294, encodeId=4b33119429492, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220112/bf73f3305cad43df9d8c6383e4c80a11/dd38f5d3971d483f90e3f37da7df323a.jpg, createdBy=13b76462298, createdName=ms尼, createdTime=Thu Feb 17 08:13:22 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083810, encodeId=103f10838103a, content=需要好好学习英文了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5bc5435970, createdName=ms5000001325769072, createdTime=Fri Dec 24 10:12:57 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083276, encodeId=b2e210832e6db, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f0d6166186, createdName=ms5000000939453647, createdTime=Wed Dec 22 23:21:19 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2021-12-24 ms5000001325769072

    需要好好学习英文了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1219468, encodeId=f9a61219468cc, content=学习了，收益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6de78157387, createdName=ms5000001899709557, createdTime=Fri May 13 21:26:40 CST 2022, time=2022-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203654, encodeId=f2ea1203654a2, content=好好学习，才能在临床从容不迫！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hkBfzo6cRvbR7e9fJhbElibI77mNBsDDibeHJyWjA4UdPoicSViaMb9ddJjJHUSia6M6FNHpmcrJiaQibJwfiab9tIGIVg/132, createdBy=26d31663249, createdName=1ddf3cfcm49(暂无匿称), createdTime=Fri Mar 18 00:00:34 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194294, encodeId=4b33119429492, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220112/bf73f3305cad43df9d8c6383e4c80a11/dd38f5d3971d483f90e3f37da7df323a.jpg, createdBy=13b76462298, createdName=ms尼, createdTime=Thu Feb 17 08:13:22 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083810, encodeId=103f10838103a, content=需要好好学习英文了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5bc5435970, createdName=ms5000001325769072, createdTime=Fri Dec 24 10:12:57 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083276, encodeId=b2e210832e6db, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f0d6166186, createdName=ms5000000939453647, createdTime=Wed Dec 22 23:21:19 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2021-12-22 ms5000000939453647

    学习了

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2020 ECAS意见书：临床分型和亚临床房颤的挑战

欧洲心律协会(ECAS,European Cardiac Arrhythmia Society) · 2020-10-13

2020 ESC/EACTS心房颤动诊断和管理指南

欧洲心脏病学会(ESC,European Society of Cardiology) · 2020-08-29

2020 AHA科学声明：减轻房颤的生活方式和危险因素调整

美国心脏协会(AHA,American Heart Association) · 2020-03-09

2019 HRS/ACP心房颤动筛查和教育倡议的解读

暂未更新 · 2019-11-30

2019 HRS/ACP 房颤筛查和教育倡议

美国医师协会(ACP,American College of Physicians) · 2019-08-01

2018 CHEST指南：房颤抗栓治疗

美国胸科医师学会(ACCP,American College of Chest Physicians) · 2018-08-21

拓展阅读

2010ESC 欧洲心脏病学会房颤管理指南

欧洲心脏病学会(ESC,European Society of Cardiology) · 2010-09-10

心房颤动：目前的认识和治疗建议-2010

中华医学会心电生理和起搏分会 · 2010-10-30

2010 CCS 加拿大心血管学会房颤指南：导管消融用于心房颤动/心房扑动

加拿大心血管学会(CCS,Canadian Cardiovascular Society) · 2010-11-01

2010 CCS 加拿大心血管学会房颤指南：近期发作的房颤和房扑的急诊处理

加拿大心血管学会(CCS,Canadian Cardiovascular Society) · 2010-11-10

2011ACCF/AHA/HRS心房颤动治疗指南(更新2006版指南）

美国心脏病学会基金会(ACCF,American College of Cardiology Foundation) · 2010-12-20

2010 CCS 加拿大心血管学会房颤指南：房颤和房扑时中风和全身性血栓栓塞的预防

加拿大心血管学会(CCS,Canadian Cardiovascular Society) · 2011-01-01